Zolmitriptan Tablet, Film Coated
Product Images NDC 68462-498

6 FDA label images from Glenmark Pharmaceuticals Inc.,usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 68462-498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc.,usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton2pt5mg6s

Carton2pt5mg6s
Packaging label for Zolmitriptan Tablets, USP 2.5 mg, film-coated oral tablets. The label contains the product name and strength multiple times, indicates Rx only, and shows a package size of 6 unit-dose tablets. Manufactured by Glenmark Pharmaceuticals Ltd., India, and manufactured for Glenmark Pharmaceuticals Inc., USA. Storage and warning information are also included, along with a barcode and contact details.*
FDA Label Image

Carton5mg3s

Carton5mg3s
The packaging label for Zolmitriptan Tablets, USP 5 mg film-coated oral tablets. The label shows the product name and strength prominently, indicates the package contains 3 unit-dose tablets, and includes Glenmark Pharmaceuticals Inc., USA as the labeler. Storage instructions and warning to keep out of reach of children are also present. Barcodes and contact information for Glenmark Pharmaceuticals are visible.*
FDA Label Image

Figure1

Figure1
A line graph illustrating estimated probability of response over a 4-hour period after initial dose, comparing placebo with zolmitriptan at 1 mg, 2.5 mg, and 5 mg doses. The graph shows increasing response probabilities for all zolmitriptan doses versus placebo over time.*
FDA Label Image

Figure2

Figure2
A line graph showing the estimated probability over 24 hours of rescue medication use after initial dose with placebo and zolmitriptan doses (1 mg, 2.5 mg, 5 mg). The Y-axis represents probability from 0% to 100%, and the X-axis is time in hours. Higher doses show lower probability of using rescue medication.*
FDA Label Image
FDA Label Image

Structre

Structre
Chemical structure diagram of zolmitriptan illustrating its molecular framework including key functional groups and ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.